Phentermine hydrochloride

185.69

185.09700

214-821-9

0K2I505OTV

1640

44090

DTXSID20152550

C29361

2921499090

26.02000

3.46870

198 °C

206ºC at 760mmHg

93.1ºC

In water, 1.8X10+4 mg/L at 25 deg C (est)

Phentermine hydrochloride capsules and tablets should be stored in tight and well-closed containers, respectively, at a temperature less than 40 deg C, preferably at 15-30 deg C. Capsules containing phentermine as a resin complex should be stored in tight containers at 15-30 deg C. . /Phentermine hydrochloride/

9.6X10-2 mm Hg at 25 deg C (est)

UN 2811 6.1/PG 3

3

25

22-26-36/37-45

SH4950000

T,Xi

Irritant

Missing Phrase - N15.00950417

H301

|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P264, P270, P301+P310, P321, P330, P405, and P501|Aggregated GHS information provided by 139 companies from 1 notifications to the ECHA C&L Inventory.

Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)|Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)|Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)|A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)

Adipex P

Phentermine|Ionamin, Fastin, Adipex-P, Obe-Nix, Zantryl|1640|Schedule IV - Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.|No

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients